Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating biomarkers in hepatocellular carcinoma.
Morris KL, Tugwood JD, Khoja L, Lancashire M, Sloane R, Burt D, Shenjere P, Zhou C, Hodgson C, Ohtomo T, Katoh A, Ishiguro T, Valle JW, Dive C. Morris KL, et al. Among authors: zhou c. Cancer Chemother Pharmacol. 2014 Aug;74(2):323-32. doi: 10.1007/s00280-014-2508-7. Epub 2014 Jun 13. Cancer Chemother Pharmacol. 2014. PMID: 24923562
Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
Khoja L, Lorigan P, Zhou C, Lancashire M, Booth J, Cummings J, Califano R, Clack G, Hughes A, Dive C. Khoja L, et al. Among authors: zhou c. J Invest Dermatol. 2013 Jun;133(6):1582-90. doi: 10.1038/jid.2012.468. Epub 2012 Dec 6. J Invest Dermatol. 2013. PMID: 23223143 Free article.
A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers.
Simpson KL, Cawthorne C, Zhou C, Hodgkinson CL, Walker MJ, Trapani F, Kadirvel M, Brown G, Dawson MJ, MacFarlane M, Williams KJ, Whetton AD, Dive C. Simpson KL, et al. Among authors: zhou c. Cell Death Dis. 2013 May 2;4(5):e613. doi: 10.1038/cddis.2013.137. Cell Death Dis. 2013. PMID: 23640455 Free PMC article.
The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer.
Backen A, Renehan AG, Clamp AR, Berzuini C, Zhou C, Oza A, Bannoo S, Scherer SJ, Banks RE, Dive C, Jayson GC. Backen A, et al. Among authors: zhou c. Clin Cancer Res. 2014 Sep 1;20(17):4549-4558. doi: 10.1158/1078-0432.CCR-13-3248. Epub 2014 Jun 19. Clin Cancer Res. 2014. PMID: 24947924 Free PMC article. Clinical Trial.
21,222 results
You have reached the last available page of results. Please see the User Guide for more information.